Clinical Trial Update: Analysis of a Beneficial Effect of Prolonges Topical Steroid Treatment After Low-risk Penetrating Keratoplasty [NA]

View source ↗

Summary

Completed clinical trial suggests that prolonged topical corticosteroid treatment after low-risk penetrating keratoplasty may reduce graft rejection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Graft Rejection

Drugs mentioned

• Topical corticosteroids (Corticosteroid)

Snippet

Sponsor: University of Erlangen-Nürnberg Medical School | Conditions: Graft Rejection | NA | Status: COMPLETED